Home › NDC Lookup › RxCUI directory › RxCUI 2586377

Vosoritide 1.2 MG Injection [Voxzogo] — RxCUI 2586377

RxNorm drug concept · Semantic branded drug
RxCUI 2586377 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2586377
Official nameVosoritide 1.2 MG Injection [Voxzogo]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asVoxzogo 1.2 MG Injection
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)1,319 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Vosoritide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • VOXZOGO works by releasing the biological brake that achondroplasia puts on your child's bone growth. In clinical trials, children using it grew faster than those on placebo. That...
  • What exactly does VOXZOGO do, and will it make my child grow to a normal height?
  • Your care team will walk you through the full process before you do it at home — so don't worry, you won't be sent home to figure it out alone. Each day you'll mix the powder with...
  • How do I give this injection at home, and does it hurt my child?
📖 Read our full Vosoritide guide →

🕸️ Concept Web — How Vosoritide 1.2 MG Injection [Voxzogo] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Vosoritide 1.2 MG Injection [Voxzogo] RxCUI 2586377

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Vosoritide 2586354
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Voxzogo 2586365
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Vosoritide Injection 2586363
    • Vosoritide Injectable Product 2586362
    • Vosoritide Injection [Voxzogo] 2586368
    • Voxzogo Injectable Product 2586367
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Vosoritide 1.2 MG Injection SCD · 2586375
  • Vosoritide 1.2 MG SCDC · 2586374
  • Vosoritide Injection SCDF · 2586363
  • Vosoritide Injectable Product SCDG · 2586362

Brand-Name Concepts

  • Vosoritide 1.2 MG [Voxzogo] SBDC · 2586376
  • Vosoritide Injection [Voxzogo] SBDF · 2586368
  • Voxzogo Injectable Product SBDG · 2586367
  • Voxzogo BN · 2586365

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 2586377 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68135-0082-36 1 KIT in 1 CARTON (68135-082-36) * 10 VIAL, SINGLE-DOSE in... VOXZOGO 0.4mg BioMarin Pharmaceutical Inc. 2021-11-19
68135-0119-66 1 KIT in 1 CARTON (68135-119-66) * 10 VIAL, SINGLE-DOSE in... VOXZOGO 0.56mg BioMarin Pharmaceutical Inc. 2021-11-19
68135-0181-93 1 KIT in 1 CARTON (68135-181-93) * 10 VIAL, SINGLE-DOSE in... VOXZOGO 1.2mg BioMarin Pharmaceutical Inc. 2021-11-19
Observed labelers: BioMarin Pharmaceutical Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.